There is no stronger risk factor for cancer than age.
At the time of diagnosis, the median age of patients across all cancers is 66. That moment, however, is the culmination of years of clandestine tumor growth, and the answer to an important question has thus far remained elusive: When does a cancer first arise?
At least in some cases, the original cancer-causing mutation could have appeared as many as 40 years ago, according to a new study by researchers at Harvard Medical School and the Dana-Farber Cancer Institute.
Reconstructing the lineage history of cancer cells in two individuals with a rare blood cancer, the team calculated when the genetic mutation that gave rise to the disease first appeared. In a 63-year-old patient, it occurred at around age 19; in a 34-year-old patient, at around age 9.
The findings, published in the March 4, 2021, issue of Cell Stem Cell, add to a growing body of evidence that cancers slowly develop over long periods of time before manifesting as a distinct disease. The results also present insights that could inform new approaches for early detection, prevention, or intervention.
For both of these patients, it was almost like they had a childhood disease that just took decades and decades to manifest, which was extremely surprising, said co-corresponding study author Sahand Hormoz, assistant professor of systems biology at HMS and Dana-Farber.
I think our study compels us to ask, when does cancer begin, and when does being healthy stop? Hormoz said. It increasingly appears that its a continuum with no clear boundary, which then raises another question: When should we be looking for cancer?
In their study, Hormoz and colleagues focused on myeloproliferative neoplasms (MPNs), a rare type of blood cancer involving the aberrant overproduction of blood cells. The majority of MPNs are linked to a specific mutation in the gene JAK2. When the mutation occurs in bone marrow stem cells, the bodys blood cell production factories, it can erroneously activate JAK2 and trigger overproduction.
To pinpoint the origins of an individuals cancer, the team collected bone marrow stem cells from two patients with MPN driven by the JAK2 mutation. The researchers isolated a number of stem cells that contained the mutation, as well normal stem cells, from each patient, and then sequenced the entire genome of each individual cell.
Over time and by chance, the genomes of cells randomly acquire so-called somatic mutationsnonheritable, spontaneous changes that are largely harmless. Two cells that recently divided from the same mother cell will have very similar somatic mutation fingerprints. But two distantly related cells that shared a common ancestor many generations ago will have fewer mutations in common because they had the time to accumulate mutations separately.
Analyzing these fingerprints, Hormoz and colleagues created a phylogenetic tree, which maps the relationships and common ancestors between cells, for the patients stem cellsa process similar to studies of the relationships between chimpanzees and humans, for example.
We can reconstruct the evolutionary history of these cancer cells, going back to that cell of origin, the common ancestor in which the first mutation occurred, Hormoz said.
Combined with calculations of the rate at which mutations accumulate, the team could estimate when the JAK2 mutation first occurred. In the patient who was first diagnosed with MPN at age 63, the team found that the mutation arose around 44 years prior, at the age of 19. In the patient diagnosed at age 34, it arose at age 9.
By looking at the relationships between cells, the researchers could also estimate the number of cells that carried the mutation over time, allowing them to reconstruct the history of disease progression.
Initially, theres one cell that has the mutation. And for the next 10 years theres only something like 100 cancer cells, Hormoz said. But over time, the number grows exponentially and becomes thousands and thousands. Weve had the notion that cancer takes a very long time to become an overt disease, but no one has shown this so explicitly until now.
The team found that the JAK2 mutation conferred a certain fitness advantage that helped cancerous cells outcompete normal bone marrow stem cells over long periods of time. The magnitude of this selective advantage is one possible explanation for some individuals faster disease progression, such as the patient who was diagnosed with MPN at age 34.
In additional experiments, the team carried out single-cell gene expression analyses in thousands of bone marrow stem cells from seven different MPN patients. These analyses revealed that the JAK2 mutation can push stem cells to preferentially produce certain blood cell types, insights that may help scientists better understand the differences between various MPN types.
Together, the results of the study offer insights that could motivate new diagnostics, such as technologies to identify the presence of rare cancer-causing mutations currently difficult to detect, according to the authors.
To me, the most exciting thing is thinking about at what point can we detect these cancers, Hormoz said. If patients are walking into the clinic 40 years after their mutation first developed, could we have caught it earlier? And could we prevent the development of cancer before a patient ever knows they have it, which would be the ultimate dream?
The researchers are now further refining their approach to studying the history of cancers, with the aim of helping clinical decision-making in the future.
While their approach is generalizable to other types of cancer, Hormoz notes that MPN is driven by a single mutation in a very slow growing type of stem cell. Other cancers may be driven by multiple mutations, or in faster-growing cell types, and further studies are needed to better understand the differences in evolutionary history between cancers.
The teams current efforts include developing early detection technologies, reconstructing the histories of greater numbers of cancer cells, and investigating why some patients mutations never progress into full-blown cancer, but others do.
Even if we can detect cancer-causing mutations early, the challenge is to predict which patients are at risk of developing the disease, and which are not, Hormoz said. Looking into the past can tell us something about the future, and I think historical analyses such as the ones we conducted can give us new insights into how we could be diagnosing and intervening.
Reference: Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms by Debra Van Egeren, Javier Escabi, Maximilian Nguyen, Shichen Liu, Christopher R. Reilly, Sachin Patel, Baransel Kamaz, Maria Kalyva, Daniel J. DeAngelo, Ilene Galinsky, Martha Wadleigh, Eric S. Winer, Marlise R. Luskin, Richard M. Stone, Jacqueline S. Garcia, Gabriela S. Hobbs, Fernando D. Camargo, Franziska Michor and Ann Mullally, 22 February 2021, Cell Stem Cell.DOI: 10.1016/j.stem.2021.02.001
Study collaborators include scientists and physicians from Brigham and Womens Hospital, Boston Childrens Hospital, Massachusetts General Hospital, and the European Bioinformatics Institute. The other co-corresponding authors of the study are Ann Mullally and Isidro Corts-Ciriano.
Additional authors include Debra Van Egeren, Javier Escabi, Maximilian Nguyen, Shichen Liu, Christopher Reilly, Sachin Patel, Baransel Kamaz, Maria Kalyva, Daniel DeAngelo, Ilene Galinsky, Martha Wadleigh, Eric Winer, Marlise Luskin, Richard Stone, Jacqueline Garcia, Gabriela Hobbs, Fernando Camargo, and Franziska Michor.
The study was supported in part by the National Institutes of Health (grants R00GM118910, R01HL158269), the Jayne Koskinas Ted Giovanis Foundation for Health and Policy, the William F. Milton Fund at Harvard University, an AACR-MPM Oncology Charitable Foundation Transformative Cancer Research grant, Gabrielles Angel Foundation for Cancer Research, and the Claudia Adams Barr Program in Cancer Research.
Continue reading here:
- Cellino Biotech developing tech to help scale stem cell therapies - MedCity News - April 14th, 2021
- Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021: Methods of Commercializing iPSCs are Diverse and Continue to Expand -... - April 14th, 2021
- A Massive New Gene Editing Project Is Out to Crush Alzheimer's - Singularity Hub - April 14th, 2021
- eQcell Inc Announces the Appointment of Members of the Board of Directors - BioSpace - April 14th, 2021
- Researchers Receive Grant to Improve Cellular Therapies to Treat 'Incurable' Diseases - University of Arkansas Newswire - April 14th, 2021
- Lonza Celebrates 20th Anniversary of Nucleofector Cell Transfection Platform - Technology Networks - April 14th, 2021
- New consortium aims to accelerate development of stem cell-based therapies for Huntingtons disease - News-Medical.Net - April 10th, 2021
- Strengthening the Stem Cell Industry Through Better Regulation - The Regulatory Review - April 10th, 2021
- Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021: Research, Patents, Funding Events, Industry Partnerships, Biomedical... - April 10th, 2021
- Stem Cell Transplantation May Be Offered Less Often as a Treatment Option for Some Patients with Mantle Cell Lymphoma - Curetoday.com - April 10th, 2021
- Real-time imaging shines light on the coordination of neural stem cell activation - News-Medical.net - April 10th, 2021
- Searching for Molecular Targets in Myeloid Malignancies and Beyond - OncLive - April 10th, 2021
- Fitore Nutrition Launches Spectrum + to Better the Lives of Children With Autism - Influencive - April 10th, 2021
- Cancer Stem Cells Market By Size Estimation, Growth Rate, Regional Analysis With with the CAGR of 11.0% Over the Forecast Period. KSU | The Sentinel... - April 10th, 2021
- global market for regenerative medicines is predicted to grow at a CAGR of 13.99% over the forecast period of 2020-2030 - GlobeNewswire - April 10th, 2021
- Adipose Derived Stem Cell Therapy Market New Business Opportunities And Investment Research Report 2020-2027 | Coherent Market Insights KSU | The... - April 10th, 2021
- Celularity Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021 - GlobeNewswire - April 10th, 2021
- New local publication and book-signing event - Bowling Green Daily News - April 6th, 2021
- Human blastocyst-like structures generated entirely from pluripotent stem cells. Shifting the paradigm of developmental biology? - ESHRE - April 3rd, 2021
- Comprehensive Report on Stem Cell Therapy Market 2021 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Cellular Dynamics... - April 3rd, 2021
- New approach to CAR T gene therapy yields efficient and longer-lasting response against HIV - News-Medical.Net - April 3rd, 2021
- New research offers hope to women with POI - Austin Daily Herald - Austin Herald - April 3rd, 2021
- Stem Cell Therapy Market to Witness Strong Growth Over 2021-2027 | Key Manufacturers Overview- Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals,... - April 3rd, 2021
- The entelechy test: embryos and simbryos - BioNews - March 30th, 2021
- Multiple sclerosis: Recent research on causes and treatments - Medical News Today - March 30th, 2021
- Global Regenerative Medicine Conference, NCRM NICHE with Fujio Cup Quiz (FCQ), E-poster and Edogawa NICH - Times of India - March 30th, 2021
- Study: Anti-Inflammatory Therapies Could Reduce Heart Disease Risk in Elderly Patients With Clonal Hematopoiesis - Pharmacy Times - March 30th, 2021
- Can This New Electrophysiology Technology Boost Neurology Research? - Labiotech.eu - March 30th, 2021
- Stem Cell Characterization and Analysis ToolMarket Size, Share, Industry Analysis, Forecast and Global Research Report to 2027 - The Market Eagle - March 30th, 2021
- Researchers describe the systems that manage embryonic stem cells - Microbioz India - March 26th, 2021
- Cell therapy player Fate Therapeutics sees CSO and 12-year veteran Shoemaker retire - FierceBiotech - March 26th, 2021
- Stem cells - a mix of promise and hype - ABC News - March 26th, 2021
- Global Vaccine, Insulin and Stem Cell Market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis 2020-2026 The Bisouv Network... - March 26th, 2021
- Stem cell therapy could help restore debilitating age-related muscle loss - News-Medical.Net - March 24th, 2021
- Cell Culture: Disrupting the Meat Industry - Open Access Government - March 24th, 2021
- Canine Stem Cell Therapy Market Research and New Developments 2021-2026 KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper - March 24th, 2021
- Two In-Space Production Applications and Calls for Proposals Announced - Genetic Engineering & Biotechnology News - March 24th, 2021
- Hematopoietic Stem Cell Transplantation (HSCT) Market 2020-2027 Onset of Advanced Technologies to Upsurge the Growth The Courier - The Courier - March 24th, 2021
- Trending News: Stem Cell Cartilage Regeneration Market New Research Report 2021 to 2027| Anika Therapeutics, Zimmer Biomet, BioTissue Technologies -... - March 24th, 2021
- Researchers Have Grown 'Human Embryos' From Skin Cells. Is It Ethical? - The Wire Science - March 20th, 2021
- Stem cell therapy could help bear recover from painful disease - FOX 35 Orlando - March 20th, 2021
- The J&J vaccine was developed with stem cells. Thats caused confusion and division among Catholics. - OregonLive - March 20th, 2021
- Adipose-derived Stem Cell Overview Market Trend, Growth, Size, Forecast, Key Players and Competitive Landscape Research Report by2027 The Courier -... - March 20th, 2021
- Scientists Grow Tear Gland Organoids That Can Actually Cry - Freethink - March 20th, 2021
- Rheumatoid Arthritis Stem Cell Therapy Market Predicted to Witness Surge in the Near Future 2018 to 2028 KSU | The Sentinel Newspaper - KSU | The... - March 18th, 2021
- Catholic opinions on Johnson & Johnson vaccine highlight debate between hardliners on abortion and others in the church - Fairfield Citizen - March 18th, 2021
- Super-resolution system microscopy can reveal pluripotency and differentiation of live stem cells - News-Medical.net - March 11th, 2021
- New multi-faculty Centre for Cell Therapy Translation gives UCalgary skin in the game for regenerative medicine research - UCalgary News - March 11th, 2021
- Policymakers urged to extend the 14-day limit on embryo research - BioNews - March 11th, 2021
- The Sacramento Business Journal announced that Cate Dyer, CEO, and founder of StemExpress, has been selected as one of SBJ's 2021 Most Admired CEOs -... - March 11th, 2021
- Coronavirus Insights: Ongoing Updates Covering The Impact On Induced Pluripotent Stem Cell Market - The Courier - March 11th, 2021
- Longeveron and University of Miami Expand Exclusive License Agreement, and Enter into CRADA To Facilitate Future Collaborations - GlobeNewswire - March 11th, 2021
- Adipose Stem Cells (ASCS) Market 2021 Global Analysis and Outlook: LifeCell, EMD Millipore, Geron, BrainStorm Cell Therapeutics, Minerva... - March 11th, 2021
- Stem cells: Therapy, controversy, and research - March 5th, 2021
- Human embryo research beyond the primitive streak - Science - March 5th, 2021
- Research Antibodies Market Size to Reach USD 5325.8 Million by 2027 | Increasing R&D Activities in the Fields of Oncology, Neurobiology, and Stem... - March 5th, 2021
- Stem Cell Therapy Market Research Reveals Enhanced Growth During The Forecast Period 2017 2025 FLA News - FLA News - March 5th, 2021
- Astrocytes Derived from Patients with Bipolar Disorder Malfunction - UC San Diego Health - March 5th, 2021
- Global Stem Cell Therapy Market Booming Market To Hit $ 18.66 Billion By 2027 With Top Key Players Osiris Therapeutics, Inc. (US), MEDIPOST Co., Ltd.... - March 5th, 2021
- Stem Cell Derived Exosome Production in Stirred-Tank Bioreactors - BioProcess Insider - March 5th, 2021
- Researchers study iPSCs to uncover genetic causes of disease - Drug Target Review - March 5th, 2021
- Moderna Hires Harvard Stem Cell Researcher Jonathan Hoggatt as Director of Hematology: What You Need to Know - Benzinga - March 5th, 2021
- Intrapericardial injection provides a less invasive means of treating cardiac injury - News-Medical.Net - March 5th, 2021
- Individualized brain cell grafts reverse Parkinson's symptoms in monkeys - University of Wisconsin-Madison - March 3rd, 2021
- New Controversy for Stem Cell Therapy That Repairs Spinal Cords - The Great Courses Daily News - March 3rd, 2021
- Cell Therapy Company Raises $160 Million to Advance iPSC-Derived Therapies to Clinic - BioSpace - March 3rd, 2021
- NSAIDs to Treat Arthritic Canines Through 2028; Stem Cell Therapies to Invigorate Canine Arthritis T - PharmiWeb.com - March 3rd, 2021
- A region within GLI1 gene could potentially be targeted as cancer treatment - News-Medical.Net - March 3rd, 2021
- Magenta Therapeutics Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Program Highlights - Galveston County Daily News - March 3rd, 2021
- Global Animal Stem Cell Therapy Market 2020 2025 Research Report Segment Outlook, Growth Potentials and Analysis of COVID-19 Worldwide Outbreak KSU... - March 3rd, 2021
- Global Autologous stem cell and Non-stem cell based Therapies Market- Industry Analysis, Growth, Segmentation and Forecast-2019-2027 - The Bisouv... - March 3rd, 2021
- Stem Cell manufacturing Market Witness an Outstanding Growth and Strong Revenue and Forecast 2027 KSU | The Sentinel Newspaper - KSU | The Sentinel... - March 3rd, 2021
- New study launches into COVID-19 vaccine responses in patients with impaired immune systems - University of Birmingham - March 3rd, 2021
- U. Cancer Center pilot projects: investigating cancer connections - The Brown Daily Herald - March 3rd, 2021
- Animal Stem Cell Therapy Market Size 2021 | Global Trends, Business Overview, Challenges, Opportunities and Forecast to 2027 The Bisouv Network - The... - March 1st, 2021
- Human Lung and Brain Organoids Respond Differently to SARS-CoV-2 Infection in Lab Tests - UC San Diego Health - March 1st, 2021
- Contemporary Critical Care Complications of Stem Cell Transplant/Cellular Therapies - TMC News - Texas Medical Center News - March 1st, 2021
- Global Human Embryonic Stem Cells Market Size-Share Analysis and System Production | Addressing the Potential Impact of COVID-19 Top Companies FLA... - February 21st, 2021
- Studies Show ApoE4 Carriers Appear More Susceptible to COVID-19Experts Say the Jury Is Still Out - Being Patient - February 21st, 2021
- Global Stem Cell Therapy Market 2020 | Demand and Scope with Outlook, Business Strategies, Challenges and Forecasts to 2025 KSU | The Sentinel... - February 19th, 2021